Imunon, Inc.·4

Jun 29, 4:35 PM ET

Faller Douglas Vincent 4

4 · Imunon, Inc. · Filed Jun 29, 2026

Research Summary

AI-generated summary of this filing

Updated

Imunon (IMNN) CMO Douglas Faller Receives 21,896-Share Award

What Happened

  • Douglas Vincent Faller, Chief Medical Officer of Imunon, Inc. (IMNN), was granted 21,896 shares on June 25, 2026. The shares were valued at $1.72 each, for a total reported value of $37,661. This was an award/acquisition (not an open-market purchase or sale).

Key Details

  • Transaction date and terms: 2026-06-25 — 21,896 shares @ $1.72 per share (A: award/grant)
  • Reported value: $37,661
  • Shares owned after transaction: not disclosed in the filing
  • Footnote: F1 — stock was granted in lieu of cash for 50% of the 2025 annual cash bonus
  • Filing: Form 4 filed 2026-06-29; this filing date is within the typical two-business-day reporting window for a 2026-06-25 transaction (timely)

Context

  • This award represents compensation (a bonus paid in stock), which is routine for executives and does not necessarily signal the insider’s personal trading view. Such non-open-market grants are distinct from purchases or sales and mainly reflect company compensation policy rather than a direct buy/sell sentiment.

Insider Transaction Report

Form 4
Period: 2026-06-25
Faller Douglas Vincent
Chief Medical Officer
Transactions
  • Award

    Common Stock

    [F1]
    2026-06-25$1.72/sh+21,896$37,66121,896 total
Footnotes (1)
  • [F1]Stock granted in lieu of cash for 50% of 2025 annual cash bonus
Signature
/s/ Susan Eylward, Attorney-in-Fact for Douglas Faller|2026-06-29

Documents

1 file
  • 4
    rdgdoc.xmlPrimary

    FORM 4